Organ sparing to cure stage IV rectal cancer: A case report and review of literature

Table 2 Oncologic and surgical treatment

Patient No.	Preoperative treatment	Liver surgery			Rectal strategy				Postoperative treatment
		Type	PVE	Two stage	Restaging	Type	Delay1	Histologic analysis
1	Folfox × 12 then CRT	Major hepatectomy	1	0	T0N0	LE	9	T0R0	0
2	Folfiri × 6 then CRT	Segmentectomy	0	0	T0N0	LE	11	T0R0	Patient’s refusal
3	Folfox × 10 then CRT	Major hepatectomy	0	0	T1N0	LE	9	T0R0	0
4	Folfox × 4 then CRT	Major hepatectomy	0	0	T0N0	LE	12	T2R0 (TRG1)	Folfiri-cetux × 8
5	Folfirinox × 8 then CRT	Major hepatectomy + Tum + RF	1	1	T2N0	LE	11	T0R0
6	Folfirinox × 6 then CRT	Major hepatectomy + Tum + RF	1	1	T1N0	LE	10	T2R0 (TRG1)	Folfox × 6
7	Folfirinox × 4 then CRT	Tum + RF	0	0	T0N0	WW	-	-	Folfox × 8
8	Folfiri cetux × 6 then CRT	Tum + segmentectomy	0	0	T0N0	WW	-	-	Folfox × 6

¹Delay between the end of chemoradiation and rectal surgery. CRT: Chemoradiation; PVE: Portal vein embolization; RF: Radiofrequence; LE: Local excision; WW: Watch and wait; TRG: Tumor regression grade.